InnoSIGN Launches New Suite Products for Pharmaceutical Research and Clinical Studies
Accesswire
*Analysis of aberrant pathway signaling provides the greatest insight into targeted therapies*
*MASON, OH and EINDHOVEN,..
Wnt signaling pathway
News and Video Search Results
News coverage
-
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
GlobeNewswire
-
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
GlobeNewswire
-
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
GlobeNewswire
-
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
- More about:
Brain
0 shares
1 views
You might like
Wnt signaling pathway media coverage
Research Offers Hope For Preventing Post-COVID ‘Brain Fog’ By Targeting Brain’s Blood Vessels
Eurasia Review
Among the many confounding symptoms in patients recovering from a COVID-19 infection are memory loss and difficulty learning. Yet..
-
Surrozen Provides Corporate Update on Clinical Programs
GlobeNewswire
-
VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo
GlobeNewswire
-
Allarity’s Early Phase 2 Stenoparib Data Indicates Clinical Benefit in Women with Advanced Ovarian Cancer Selected with DRP® Companion Diagnostic
GlobeNewswire
-
Cytovation Reports Promising Interim Results from Phase 1/2a CICILIA Study with CyPep-1 in Solid Tumors
GlobeNewswire
Advertisement
More coverage
Can-Fite Novel Approach for the Treatment of Pancreatic Carcinoma with Namodenoson Receives Appreciation of the American Association of Cancer Research (AACR)
Business Wire
PETACH TIKVA, Israel--(BUSINESS WIRE)---- $CANF--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology..
-
Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke
GlobeNewswire
-
Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress
GlobeNewswire
-
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
GlobeNewswire
-
DelveInsight Highlights Major Advances, Transformative Therapies, and 15+ Leading Players Wheeling the Degenerative Disc Disease Pipeline Landscape
GlobeNewswire